MedPath

Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps (Yasargil-1)

Completed
Conditions
Gynecologic Cancer
Interventions
Procedure: Laparoscopic ultra-radical lymph node debulking
Registration Number
NCT05318170
Lead Sponsor
University of Palermo
Brief Summary

Although several studies have demonstrated the overall benefits of a laparoscopic approach for pelvic and para-aortic lymphadenectomy, complications remain a challenging scenario. Vascular injury occurs in 0.3% to 1.0% of laparoscopic procedures, with potentially lethal consequences. Vascular injuries are usually managed using coagulation, clamps or vascular sutures, but if these measures fail, laparotomy is inevitable.

To date, few reports evaluated the use of minimally invasive surgery for lymph node debulking in gynecological cancer patients with metastatic bulky lymph nodes, with encouraging results, despite the small sample sizes. Nevertheless, new minimally invasive surgery techniques that may minimize intraoperative complications are necessary. Considering these elements, this multicenter retrospective analysis is aimed to evaluate intra- and post-operative surgical outcomes, after laparoscopic ultraradical lymph nodal debulking using Yasargil clamps in gynecological cancer patients with bulky lymph node metastases.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
43
Inclusion Criteria
  • At least one bulky lymph node with size ≥ 25 mm
  • Age > 18 years
  • Body mass index (BMI) < 40 kg/m²
  • Absence of abdominal adhesion syndrome and intraperitoneal dissemination at the time of laparoscopic evaluation
Exclusion Criteria
  • Disease-free interval < 6 months and/or
  • Performance status > 2 according to Eastern Cooperative Oncology Group (ECOG) criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Women affected by gynecological cancerLaparoscopic ultra-radical lymph node debulkingWomen affected by gynecological cancer (cervical, endometrial, ovarian and vulvar cancer)
Primary Outcome Measures
NameTimeMethod
ComplicationsDuring the surgery and within 30 days after the surgery

Any complication occurred

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Palermo

🇮🇹

Palermo, Sicily, Italy

© Copyright 2025. All Rights Reserved by MedPath